These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Subclonal Genomic Architectures of Primary and Metastatic Colorectal Cancer Based on Intratumoral Genetic Heterogeneity. Kim TM; Jung SH; An CH; Lee SH; Baek IP; Kim MS; Park SW; Rhee JK; Lee SH; Chung YJ Clin Cancer Res; 2015 Oct; 21(19):4461-72. PubMed ID: 25979483 [TBL] [Abstract][Full Text] [Related]
47. Neurogenomics and the role of a large mutational target on rapid behavioral change. Stanley CE; Kulathinal RJ Biol Direct; 2016 Nov; 11(1):60. PubMed ID: 27825385 [TBL] [Abstract][Full Text] [Related]
48. Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes. Dentro SC; Leshchiner I; Haase K; Tarabichi M; Wintersinger J; Deshwar AG; Yu K; Rubanova Y; Macintyre G; Demeulemeester J; Vázquez-García I; Kleinheinz K; Livitz DG; Malikic S; Donmez N; Sengupta S; Anur P; Jolly C; Cmero M; Rosebrock D; Schumacher SE; Fan Y; Fittall M; Drews RM; Yao X; Watkins TBK; Lee J; Schlesner M; Zhu H; Adams DJ; McGranahan N; Swanton C; Getz G; Boutros PC; Imielinski M; Beroukhim R; Sahinalp SC; Ji Y; Peifer M; Martincorena I; Markowetz F; Mustonen V; Yuan K; Gerstung M; Spellman PT; Wang W; Morris QD; Wedge DC; Van Loo P; Cell; 2021 Apr; 184(8):2239-2254.e39. PubMed ID: 33831375 [TBL] [Abstract][Full Text] [Related]
49. Multiregion human bladder cancer sequencing reveals tumour evolution, bladder cancer phenotypes and implications for targeted therapy. Heide T; Maurer A; Eipel M; Knoll K; Geelvink M; Veeck J; Knuechel R; van Essen J; Stoehr R; Hartmann A; Altmueller J; Graham TA; Gaisa NT J Pathol; 2019 Jun; 248(2):230-242. PubMed ID: 30719704 [TBL] [Abstract][Full Text] [Related]
50. Multiregion ultra-deep sequencing reveals early intermixing and variable levels of intratumoral heterogeneity in colorectal cancer. Suzuki Y; Ng SB; Chua C; Leow WQ; Chng J; Liu SY; Ramnarayanan K; Gan A; Ho DL; Ten R; Su Y; Lezhava A; Lai JH; Koh D; Lim KH; Tan P; Rozen SG; Tan IB Mol Oncol; 2017 Feb; 11(2):124-139. PubMed ID: 28145097 [TBL] [Abstract][Full Text] [Related]
51. Rapid clinical mutational testing of Van Haele M; Vander Borght S; Ceulemans A; Wieërs M; Metsu S; Sagaert X; Weynand B J Clin Pathol; 2020 Jan; 73(1):35-41. PubMed ID: 31296605 [TBL] [Abstract][Full Text] [Related]
52. The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program "CASCADE". Savas P; Teo ZL; Lefevre C; Flensburg C; Caramia F; Alsop K; Mansour M; Francis PA; Thorne HA; Silva MJ; Kanu N; Dietzen M; Rowan A; Kschischo M; Fox S; Bowtell DD; Dawson SJ; Speed TP; Swanton C; Loi S PLoS Med; 2016 Dec; 13(12):e1002204. PubMed ID: 28027312 [TBL] [Abstract][Full Text] [Related]
53. Spatial and temporal cancer evolution: causes and consequences of tumour diversity. Hiley CT; Swanton C Clin Med (Lond); 2014 Dec; 14 Suppl 6():s33-7. PubMed ID: 25468916 [TBL] [Abstract][Full Text] [Related]
54. The evolutionary history of 2,658 cancers. Gerstung M; Jolly C; Leshchiner I; Dentro SC; Gonzalez S; Rosebrock D; Mitchell TJ; Rubanova Y; Anur P; Yu K; Tarabichi M; Deshwar A; Wintersinger J; Kleinheinz K; Vázquez-García I; Haase K; Jerman L; Sengupta S; Macintyre G; Malikic S; Donmez N; Livitz DG; Cmero M; Demeulemeester J; Schumacher S; Fan Y; Yao X; Lee J; Schlesner M; Boutros PC; Bowtell DD; Zhu H; Getz G; Imielinski M; Beroukhim R; Sahinalp SC; Ji Y; Peifer M; Markowetz F; Mustonen V; Yuan K; Wang W; Morris QD; ; Spellman PT; Wedge DC; Van Loo P; Nature; 2020 Feb; 578(7793):122-128. PubMed ID: 32025013 [TBL] [Abstract][Full Text] [Related]
55. Changing mutational and adaptive landscapes and the genesis of cancer. Liggett LA; DeGregori J Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):84-94. PubMed ID: 28167050 [TBL] [Abstract][Full Text] [Related]
56. Functional and genetic determinants of mutation rate variability in regulatory elements of cancer genomes. Lee CA; Abd-Rabbo D; Reimand J Genome Biol; 2021 May; 22(1):133. PubMed ID: 33941236 [TBL] [Abstract][Full Text] [Related]
57. Transmissible cancers in an evolutionary context. Ujvari B; Papenfuss AT; Belov K Bioessays; 2016 Jul; 38 Suppl 1():S14-23. PubMed ID: 27417118 [TBL] [Abstract][Full Text] [Related]
58. MixClone: a mixture model for inferring tumor subclonal populations. Li Y; Xie X BMC Genomics; 2015; 16 Suppl 2(Suppl 2):S1. PubMed ID: 25707430 [TBL] [Abstract][Full Text] [Related]
59. Quantification of subclonal selection in cancer from bulk sequencing data. Williams MJ; Werner B; Heide T; Curtis C; Barnes CP; Sottoriva A; Graham TA Nat Genet; 2018 Jun; 50(6):895-903. PubMed ID: 29808029 [TBL] [Abstract][Full Text] [Related]